Daily CBD use shows inverse relation to public awareness

FOR IMMEDIATE RELEASE

 

Media hype about CBD bears no relation to its actual popularity, according to new research. In fact, CBD-Intel found that countries where the fewest people know about CBD have the greatest number of regular users of the cannabis-based substance.

A series of surveys conducted by CBD-Intel showed that those countries with the lowest awareness of CBD – Japan, Germany and France – nevertheless had the greatest percentage reporting daily use. For example in Japan, only 14% of consumers had heard of CBD – but of those who had, 90% took it daily.

It was a similar story in France, where less than a quarter of consumers (23%) had heard of CBD – yet of those who knew of it, 86% used it daily. And in Germany 77% of CBD consumers were daily users, even though only 38% of the population had heard of the cannabinoid.

“The research indicates that perhaps in certain jurisdictions CBD has developed a niche fanatical following,” said Freddie Dawson, CBD-Intel’s head of content. “These users may not be spreading the message – or if they are they certainly are not having much in the way of results – but they are deeply committed to the use of CBD products, indicating that they see results in addressing wellness issues.”

This research forms part of CBD-Intel’s ongoing analysis of global consumer CBD markets.

The surveys took in at least 1000 consumers in each country – with the UK and Germany both topping the 2000 mark. They were conducted earlier this year in the US, UK, Switzerland, Greece, Germany, France and Japan – all important markets for CBD where CBD-Intel has invested time and energy to produce unbeatable market research.

ENDS

About CBD-Intel: CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector. We provide our clients with the tools to navigate this fast-moving sector, tailor their business strategy, optimise resources and make informed decisions.

CBD-Intel’s legal and market analysts will continue to keep subscribers across the world up to date with regulatory and market developments in this exciting and ever-changing landscape. Start your free trial now to stay in the picture or ask about subscription packages and pricing.

For further information or comment, please contact us.

CBD-Intel does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CBD-Intel, does not accept any liability or responsibility for information or views published.

Print Friendly, PDF & Email